'' '' '' '' '' Prevalence of Stenotrophomonas maltophilia in Cancer Patients at a tertiary care hospital
Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2019: 96.39
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39
For more details click here

See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 11, Issue:3, March, 2022

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2022.11(3): 211-217
DOI: https://doi.org/10.20546/ijcmas.2022.1103.025


Prevalence of Stenotrophomonas maltophilia in Cancer Patients at a tertiary care hospital
Gaurav Salunke iD* and Sanjay Biswas iD
Department of Microbiology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India
*Corresponding author
Abstract:

maltophilia is an environmental bacterium, which poses an upcoming threat to Immune suppressed individuals globally. An emerging resistance to Cotrimoxazole (drug of choice), is a serious concern in clinical practice. The aim of the study was to determine the prevalence of S. maltophilia in cancer patients at a tertiary care hospital. This retrospective study was conducted from microbiological data collected from January 2020 to December 2021. Routine antimicrobial susceptibility testing to Cotrimoxazole, Levofloxacin, Ceftazidime and Minocycline was also performed. A total of 181 isolates of S maltophilia were studied. 64.4% were males and in all individuals with more than 45 years of age were most affected. It was most susceptible to Minocycline (96.7 %) and least susceptible to Cotrimoxazole (61.9%). S. maltophilia is an emerging global opportunistic pathogen in cancer patients with limited treatment options.


Keywords: maltophilia, Levofloxacin, Cotrimoxazole, Ceftazidime, Minocycline
Download this article as Download

How to cite this article:

Gaurav Salunke and Sanjay Biswas. 2022. Prevalence of Stenotrophomonas maltophilia in Cancer Patients at A Tertiary Care Hospital.Int.J.Curr.Microbiol.App.Sci. 11(3): 211-217. doi: https://doi.org/10.20546/ijcmas.2022.1103.025
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.